Correlation Between 80281LAQ8 and Tarsus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 80281LAQ8 and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 80281LAQ8 and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SANTANDER UK GROUP and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on 80281LAQ8 and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 80281LAQ8 with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 80281LAQ8 and Tarsus Pharmaceuticals.

Diversification Opportunities for 80281LAQ8 and Tarsus Pharmaceuticals

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between 80281LAQ8 and Tarsus is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding SANTANDER UK GROUP and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and 80281LAQ8 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SANTANDER UK GROUP are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of 80281LAQ8 i.e., 80281LAQ8 and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between 80281LAQ8 and Tarsus Pharmaceuticals

Assuming the 90 days trading horizon 80281LAQ8 is expected to generate 19.15 times less return on investment than Tarsus Pharmaceuticals. But when comparing it to its historical volatility, SANTANDER UK GROUP is 16.36 times less risky than Tarsus Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  1,729  in Tarsus Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  3,516  from holding Tarsus Pharmaceuticals or generate 203.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy64.37%
ValuesDaily Returns

SANTANDER UK GROUP  vs.  Tarsus Pharmaceuticals

 Performance 
       Timeline  
SANTANDER UK GROUP 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SANTANDER UK GROUP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 80281LAQ8 is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

26 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

80281LAQ8 and Tarsus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 80281LAQ8 and Tarsus Pharmaceuticals

The main advantage of trading using opposite 80281LAQ8 and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 80281LAQ8 position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.
The idea behind SANTANDER UK GROUP and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.